Removal of group B streptococci colonizing the vagina and oropharynx of mice with a bacteriophage lytic enzyme

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 1, 2005, Pages 111-117

  Cheng, Qi ^a   Nelson, Daniel ^a   Zhu, Shiwei ^a   Fischetti, Vincent A ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDASE; ANTIBIOTIC AGENT; GENOMIC DNA; GLUCOSAMINIDASE; HYDROLASE; LYSIN; PLYGBS; PROTEINASE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL CELL WALL; BACTERIAL COLONIZATION; BACTERIOPHAGE; CONTROLLED STUDY; CYTOPLASM; ESCHERICHIA COLI; FEMALE; IN VITRO STUDY; INFECTION CONTROL; MENINGITIS; MOUSE; NEWBORN INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; OROPHARYNX; PRIORITY JOURNAL; PROTEIN DOMAIN; SEPSIS; STREPTOCOCCUS AGALACTIAE; VAGINA;

ANIMALS; BACTERIOLYSIS; DISEASE MODELS, ANIMAL; ENZYMES; ESCHERICHIA COLI; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; OROPHARYNX; SEQUENCE ANALYSIS, DNA; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; VAGINA;

EID: 11244288460     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.1.111-117.2005     Document Type: Article

References (30)

1. Baker, C. J., and M. S. Edwards. 2001. Group B streptococcal infections, p. 1091-1156. In J. Remmington and J. O. Klein (ed.), Infectious diseases of the fetus and newborn infants, 5th ed. The W. B. Saunders Co., Philadelphia, Pa.
2. Benitz, W. E., J. B. Gould, and M. L. Druzin. 1999. Antimicrobial prevention of early-onset group B streptococcal sepsis: estimates of risk reduction based on a critical literature review. Pediatrics 103:1-13.
3. Boskey, E. R., K. M. Telsch, K. J. Whaley, T. R. Moench, and R. A. Cone. 1999. Acid production by vaginal flora in vitro is consistent with the rate and extent of vaginal acidification. Infect. Immun. 67:5170-5175.
4. Centers for Disease Control and Prevention. 1996. Prevention of perinatal group B streptococcal disease: a public health perspective. Morbid. Mortal. Wkly. Rep. 45:1-24.
5. Centers for Disease Control and Prevention. 2002. Prevention of perinatal group B streptococcal disease: revised guidelines from CDC. Morbid. Mortal. Wkly. Rep. 51:1-22.
6. Farley, M. M., R. C. Harvey, T. Stull, J. D. Smith, A. Schuchat, J. D. Wenger, and D. S. Stephens. 1993. A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults. N. Engl. J. Med. 328:1807-1811.
7. Fernandez, M., M. E. Hickman, and C. J. Baker. 1998. Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis. Antimicrob. Agents Chemother. 42:1517-1519.
8. Garcia, J. L., E. Garcia, A. Arrarás, P. Garcia, C. Ronda, and R. López. 1987. Cloning, purification, and biochemical characterization of the pneumococcal bacteriophage Cp-1 lysin. J. Virol. 61:2573-2580.
9. BAD promoter. J. Bacteriol. 177:4121-4130.
10. Hall, R. T., W. Barnes, W. Krishnan, D. J. Harris, P. G. Rhodes, J. Fayez, and G. L. Miller. 1976. Antibiotic treatment of parturient women colonized with group B streptococci. Am. J. Obstet. Gynecol. 124:630-634.
11. Harrison, L. H., J. Elliott, D. M. Buyer, J. P. Libonati, P. Ferrieri, L. Billmann, A. Schuchat et al. 1998. Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. J. Infect. Dis. 177:998-1002.
12. Jolles, P., and J. Jolles. 1984. What's new in lysozyme research? Mol. Cell. Biochem. 63:165-189.
13. Kalia, A., and D. E. Bessen. 2003. Presence of streptococcal pyrogenic exotoxin A and C genes in human isolates of group G streptococci. FEMS Microbiol. Lett. 219:291-295.
14. Kenyon, S. L., D. J. Taylor, W. Tarnow-Mordi et al. 2001. Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomized trial. Lancet 357:979-988.
15. Kenyon, S. L., D. J. Taylor, W. Tarnow-Mordi et al. 2001. Broad-spectrum antibiotics for spontaneous preterm labor: the ORACLE II randomized trial. Lancet 357:989-994.
16. Kuipers, O. P. 1996. Random mutagenesis by using mixtures of dNTP and dITP in PCR. Methods Mol. Biol. 57:351-356.
17. Loeffler, J. M., D. Nelson, and V. A. Fischetti. 2001. Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase. Science 294:2170-2172.
18. Loeffler, J. M., S. Djurkovic, and V. A. Fischetti. 2003. Phage lytic enzyme Cpl-1 as a novel antimicrobial for pneumococcal bacteremia. Infect. Immun. 71:6199-6204.
19. McLean, N. W., and I. J. Rosenstein. 2000. Characterization and selection of a Lactobacillus species to recolonize the vagina of women with recurrent bacterial vaginosis. J. Med. Microbiol. 49:543-552.
20. Medaglini, D., C. M. Rush, P. Sestini, and G. Pozzi. 1997. Commensal bacteria as vectors for mucosal vaccines against sexually transmitted diseases: vaginal colonization with recombinant streptococci induces local and systemic antibodies in mice. Vaccine 15:1330-1337.
21. Mercer, B. M., M. Miodovnik, G. R. Thurnau et al. 1997. Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes: a randomized controlled trial. JAMA 278:989-995.
22. Navarre, W. W., H. Ton-That, K. F. Faull, and O. Schneewind. 1999. Multiple enzymatic activities of the murein hydrolase from staphylococcal phage Ø11. J. Biol. Chem. 274:15847-15856.
23. Nelson, D., L. Loomis, and V. A. Fischetti. 2001. Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme. Proc. Natl. Acad. Sci. USA 98:4107-4112.
24. Paoletti, L. C., L. C. Madoff, and D. L. Kasper. 2000. Surface structures of group B Streptococcus important in human immunity, p. 137-153. In V. A. Fischetti, R. P. Novick, J. J. Ferretti, D. A. Portnoy, and J. I. Rood (ed.), Gram-positive pathogens. ASM Press, Washington, D.C.
25. Pass, M. A., B. M. Gary, S. Khare, and H. C. Dillon. 1979. Prospective studies of group B streptococcal infections in infants. J. Pediatr. 95:437-443.
26. Schattner, A., and K. L. Vosti. 1998. Bacterial arthritis due to beta-hemolytic streptococci of serogroups A, B, C, F, and G. Analysis of 23 cases and a review of the literature. Medicine (Baltimore) 77:122-139.
27. Schuch, R., D. Nelson, and V. A. Fischetti. 2002. A bacteriolytic agent that detects and kills Bacillus anthracis. Nature 418:884-889.
28. Turner, N. J. 2003. Directed evolution of enzymes for applied biocatalysis. Trends Biotechnol. 21:474-478.
29. Yoong, P., R. Schuch, D. Nelson, and V. A. Fischetti. 2004. Identification of a broadly active phage lytic enzyme with lethal activity against antibiotic-resistant Enterococcus faecalis and Enterococcus faecium. J. Bacteriol. 186:4808-4812.
30. Zaleznik, D. F., M. A. Rench, S. Hillier, M. A. Krohn, R. Platt, M. L. Lee, A. E. Flores, P. Ferrieri, and C. J. Baker. 2000. Invasive disease due to group B Streptococcus in pregnant women and neonates from diverse population groups. Clin. Infect. Dis. 30:276-281.